• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响斯里兰卡人群华法林代谢的药物基因组学变异的多样性。

Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans.

机构信息

Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo 8, Sri Lanka.

Department of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo 8, Sri Lanka.

出版信息

Pharmacogenomics. 2022 Nov;23(17):917-923. doi: 10.2217/pgs-2022-0026. Epub 2022 Oct 26.

DOI:10.2217/pgs-2022-0026
PMID:36285665
Abstract

To describe the diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans. Genotype data were filtered out from an anonymized database of 400 Sri Lankans, and minor allele frequencies (MAF) were calculated. Variants of , and genes were studied. Overall, and alleles had MAFs of 2.25% (95% CI: 0.80-3.70) and 10.38% (95% CI: 7.50-13.50), respectively. and alleles had MAFs of 0.13% (95% CI: 0-0.74) and 2.50% (95% CI: 0.97-4.03), respectively. MAFs of variants rs7294, rs9934438, rs8050894 and rs2884737 were 47.25% (95% CI: 42.36-52.14), 10.13% (95% CI: 7.28-13.22), 9.88% (95% CI: 7.06-12.94) and 4.88% (95% CI: 2.86-7.14), respectively. MAF of variant rs2108622 was 45.63% (95% CI: 40.87-50.63). Compared with other populations, the frequencies of some studied variants were significantly different in Sri Lankans, and these are likely to account for variability in warfarin dosage requirements.

摘要

描述影响斯里兰卡人群华法林代谢的药物基因组学变异的多样性。从 400 名斯里兰卡人的匿名数据库中筛选出基因型数据,并计算了次要等位基因频率 (MAF)。研究了 、 和 基因的变异。总体而言, 和 等位基因的 MAF 分别为 2.25%(95%CI:0.80-3.70)和 10.38%(95%CI:7.50-13.50)。 和 等位基因的 MAF 分别为 0.13%(95%CI:0-0.74)和 2.50%(95%CI:0.97-4.03)。 变体 rs7294、rs9934438、rs8050894 和 rs2884737 的 MAF 分别为 47.25%(95%CI:42.36-52.14)、10.13%(95%CI:7.28-13.22)、9.88%(95%CI:7.06-12.94)和 4.88%(95%CI:2.86-7.14)。 变体 rs2108622 的 MAF 为 45.63%(95%CI:40.87-50.63)。与其他人群相比,一些研究的变异在斯里兰卡人群中的频率有显著差异,这些差异可能导致华法林剂量需求的变异性。

相似文献

1
Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans.影响斯里兰卡人群华法林代谢的药物基因组学变异的多样性。
Pharmacogenomics. 2022 Nov;23(17):917-923. doi: 10.2217/pgs-2022-0026. Epub 2022 Oct 26.
2
Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients.VKORC1、CYP2C9、CFP4F2和GGCX基因多态性对日本儿科患者华法林剂量的影响。
Mol Diagn Ther. 2016 Aug;20(4):393-400. doi: 10.1007/s40291-016-0212-5.
3
Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.CYP2C9、VKORC1、CYP4F2和GGCX基因变异对印度南部人群华法林维持剂量的影响及一种新的药物遗传学算法解析
Eur J Clin Pharmacol. 2014 Jan;70(1):47-56. doi: 10.1007/s00228-013-1581-x. Epub 2013 Sep 10.
4
Effect of gene polymorphims on the warfarin treatment at initial stage.基因多态性对华法林初始治疗阶段的影响。
Pharmacogenomics J. 2017 Jan;17(1):47-52. doi: 10.1038/tpj.2015.81. Epub 2015 Dec 8.
5
Pharmacogenomic variants affecting efficacy and toxicity of statins in a south Asian population from Sri Lanka.影响来自斯里兰卡南亚人群他汀类药物疗效和毒性的药物基因组学变异。
Pharmacogenomics. 2023 Oct;24(15):809-819. doi: 10.2217/pgs-2023-0149. Epub 2023 Oct 25.
6
Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study.CYP2C9、VKORC1 和 CYP4F2 多态性对华法林药效学参数的影响:一项横断面研究。
Pharmacol Rep. 2021 Oct;73(5):1405-1417. doi: 10.1007/s43440-021-00256-w. Epub 2021 Apr 3.
7
The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.非遗传和遗传因素对泰国患者华法林稳定剂量的影响。
Eur J Clin Pharmacol. 2017 Aug;73(8):973-980. doi: 10.1007/s00228-017-2265-8. Epub 2017 May 26.
8
Pharmacogenetics of Warfarin in a Diverse Patient Population.华法林在不同患者人群中的药物遗传学。
J Cardiovasc Pharmacol Ther. 2019 Nov;24(6):521-533. doi: 10.1177/1074248419843530. Epub 2019 May 7.
9
A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.CYP2C9、CYP2C9 联合 VKORC1 及 CYP2C9 联合 VKORC1 和 CYP4F2 基因型指导的华法林剂量策略与传统策略相比的网络荟萃分析。
J Clin Pharm Ther. 2021 Jun;46(3):640-648. doi: 10.1111/jcpt.13334. Epub 2020 Dec 21.
10
Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.印度人群中与华法林剂量相关的CYP2C9、CYP4F2和VKORC1基因药物遗传学变异的遗传流行病学
Pharmacogenomics. 2014 Jul;15(10):1337-54. doi: 10.2217/pgs.14.88.

引用本文的文献

1
Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka.斯里兰卡南亚人群中影响抗感染药物疗效和毒性的变异体的药物基因组学分析。
BMC Infect Dis. 2025 Feb 1;25(1):153. doi: 10.1186/s12879-025-10538-w.
2
Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka.斯里兰卡南亚人群中影响免疫调节剂和生物制剂安全性和疗效的药物基因组学变异的频率。
Hum Genomics. 2024 Sep 27;18(1):107. doi: 10.1186/s40246-024-00674-w.
3
Frequency of pharmacogenomic variants affecting efficacy and safety of anti-cancer drugs in a south Asian population from Sri Lanka.
斯里兰卡南亚人群中影响抗癌药物疗效和安全性的药物基因组学变异的频率。
BMC Med Genomics. 2024 May 24;17(1):143. doi: 10.1186/s12920-024-01919-2.